Modulation of the superior cervical ganglion for the treatment of insomnia

US2018200513A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2018200513-A1
Application numberUS-201815873449-A
CountryUS
Kind codeA1
Filing dateJan 17, 2018
Priority dateJan 18, 2017
Publication dateJul 19, 2018
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This document discusses, among other things, systems and methods to electrically modulate a patient's pineal gland to control release of melatonin from the pineal gland and regulate melatonin levels of the patient, the electrically modulating the patient's pineal gland including delivering a neuromodulation waveform using at least one electrode to modulate a superior cervical ganglion or ganglia.

First claim

Opening claim text (preview).

What is claimed is: 1 . A method comprising: electrically modulating a patient's pineal gland to control release of melatonin from the pineal gland and regulate melatonin levels of the patient, the electrically modulating the patient's pineal gland including delivering a neuromodulation waveform using at least one electrode to modulate a superior cervical ganglion or ganglia. 2 . The method of claim 1 , further comprising: receiving at least one feedback signal indicative of a patient melatonin level; and adjusting the value of at least one modulation parameter of the neuromodulation waveform to adjust the patient melatonin level in response to the received at least one feedback signal. 3 . The method of claim 2 , wherein the at least one feedback signal includes at least one signal indicative of a light level. 4 . The method of claim 2 , wherein the at least one feedback signal includes at least one signal indicative of a time of day. 5 . The method of claim 2 , wherein the at least one feedback signal includes at least one signal indicative of a pulse rate, a patient position, or a patient posture. 6 . The method of claim 2 , wherein the at least one feedback signal includes an indicator of approaching morning and the at least one stimulation parameter is adjusted to provide a decreased melatonin level in response to the indicator of approaching morning. 7 . The method of claim 2 , wherein the at least one feedback signal includes an indicator of approaching evening and the at least one stimulation parameter is adjusted to provide an increased melatonin level in response to the indicator of approaching evening. 8 . The method of claim 1 , further comprising: receiving scheduling information indicative of a user provided schedule; and adjusting a value of the at least one modulation parameter of the neuromodulation waveform to adjust a patient melatonin level according to the received scheduling information. 9 . The method of claim 1 , wherein the electrically modulating the patient's pineal gland includes subcutaneously modulating the patient's pineal gland. 10 . The method of claim 1 , wherein the electrically modulating the patient's pineal gland includes transcutaneously modulating the patient's pineal gland. 11 . A system comprising: an electrode assembly configured for use to electrically modulate a superior cervical ganglion or ganglia of a patient; and control circuitry configured to control electrical modulation of a patient's pineal gland and regulate melatonin levels of the patient by controlling a neuromodulation waveform to be delivered using the electrode assembly to electrically modulate the superior cervical ganglion or ganglia of the patient. 12 . The system of claim 11 , further comprising feedback circuitry configured to receive at least one feedback signal indicative of a patient melatonin level and provide the feedback signal to the control circuitry, wherein the control circuitry is further configured to adjust a value of at least one modulation parameter of the neuromodulation waveform to adjust the patient melatonin level in response to the received at least one feedback signal. 13 . The system of claim 11 , further comprising stimulation circuitry configured to deliver the neuromodulation waveform to the at least one electrode of the patient. 14 . The system of claim 12 , wherein the at least one feedback signal includes at least one of a light level, a pulse rate, a patient position, a time of day, or a patient posture. 15 . The system of claim 12 , wherein the at least one feedback signal includes an indicator of approaching morning and wherein the control circuitry is further configured to adjust the at least one stimulation parameter to provide a decreased melatonin level in response to the indicator of approaching morning. 16 . The system of claim 12 , wherein the at least one feedback signal includes an indicator of approaching evening and wherein the control circuitry is further configured to adjust the at least one stimulation parameter to provide an increased melatonin level in response to the indicator of approaching evening. 17 . The system of claim 12 , wherein the control circuitry is further configured to adjust the value of at least one modulation parameter of the neuromodulation waveform to adjust a patient melatonin level according to scheduling information provided by a user. 18 . The system of claim 12 , wherein the at least one electrode is implantable in the patient. 19 . The system of claim 12 , wherein the at least one electrode is external to the patient. 20 . A non-transitory machine-readable medium including instructions, which when executed by a machine, cause the machine to control electrical modulation of a patient's pineal gland and regulate melatonin levels of the patient by controlling a neuromodulation waveform to be delivered using an electrode assembly to modulate the patient's pineal gland by electrically modulating a superior cervical ganglion or ganglia of the patient.

Assignees

Inventors

Classifications

  • for remote operation · CPC title

  • Implanted circuitry · CPC title

  • with a balloon · CPC title

  • Details of circuitry or electric components · CPC title

  • Inertial sensors, e.g. accelerometers, gyroscopes, tilt switches · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2018200513A1 cover?
This document discusses, among other things, systems and methods to electrically modulate a patient's pineal gland to control release of melatonin from the pineal gland and regulate melatonin levels of the patient, the electrically modulating the patient's pineal gland including delivering a neuromodulation waveform using at least one electrode to modulate a superior cervical ganglion or ganglia.
Who is the assignee on this patent?
Boston Scient Neuromodulation Corp
What technology area does this patent fall under?
Primary CPC classification A61N1/3603. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Jul 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).